These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19051325)

  • 1. Promoter methylation blocks FES protein-tyrosine kinase gene expression in colorectal cancer.
    Shaffer JM; Smithgall TE
    Genes Chromosomes Cancer; 2009 Mar; 48(3):272-84. PubMed ID: 19051325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
    Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
    BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines.
    Suh ER; Ha CS; Rankin EB; Toyota M; Traber PG
    J Biol Chem; 2002 Sep; 277(39):35795-800. PubMed ID: 12124393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer.
    Delfino FJ; Stevenson H; Smithgall TE
    J Biol Chem; 2006 Mar; 281(13):8829-35. PubMed ID: 16455651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor.
    Deng G; Song GA; Pong E; Sleisenger M; Kim YS
    Cancer Res; 2004 Apr; 64(8):2692-8. PubMed ID: 15087381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of serum/glucocorticoid regulated kinase 1 in colorectal tumours is largely independent of promoter hypermethylation.
    Lessi F; Beggs A; de Palo M; Anti M; Macarone Palmieri R; Francesconi S; Gomes V; Bevilacqua G; Tomlinson I; Segditsas S
    PLoS One; 2010 Nov; 5(11):e13840. PubMed ID: 21079778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
    Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
    Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells.
    Côté S; Sinnett D; Momparler RL
    Anticancer Drugs; 1998 Oct; 9(9):743-50. PubMed ID: 9840718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
    Gao X; Tang C; Shi W; Feng S; Qin W; Jiang T; Sun Y
    Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer.
    Rawluszko AA; Bujnicka KE; Horbacka K; Krokowicz P; Jagodziński PP
    BMC Cancer; 2013 Nov; 13():526. PubMed ID: 24195777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation.
    Tae CH; Ryu KJ; Kim SH; Kim HC; Chun HK; Min BH; Chang DK; Rhee PL; Kim JJ; Rhee JC; Kim YH
    BMC Cancer; 2013 Mar; 13():142. PubMed ID: 23517143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.
    Cheetham S; Tang MJ; Mesak F; Kennecke H; Owen D; Tai IT
    Br J Cancer; 2008 Jun; 98(11):1810-9. PubMed ID: 18458674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
    Li DJ; Feng ZC; Li XR; Hu G
    World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Aza-2'-deoxycytidine leads to down-regulation of aberrant p16INK4A RNA transcripts and restores the functional retinoblastoma protein pathway in hepatocellular carcinoma cell lines.
    Suh SI; Pyun HY; Cho JW; Baek WK; Park JB; Kwon T; Park JW; Suh MH; Carson DA
    Cancer Lett; 2000 Nov; 160(1):81-8. PubMed ID: 11098088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
    Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
    Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer.
    Kondo Y; Shen L; Issa JP
    Mol Cell Biol; 2003 Jan; 23(1):206-15. PubMed ID: 12482974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of neutral endopeptidase 24.11 promoter in rat hepatocellular carcinoma.
    Uematsu F; Takahashi M; Yoshida M; Igarashi M; Nakae D
    Cancer Sci; 2006 Jul; 97(7):611-7. PubMed ID: 16827801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
    Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
    Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR
    Carcinogenesis; 2000 Sep; 21(9):1691-700. PubMed ID: 10964101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.